Second-degree atrioventricular block as the first sign of sarcoidosis in a previously asymptomatic patient

Acta Cardiologica

Volumn 62, Issue 3, 2007, Pages 299-301

  Van Herendael, Bruno ^a   Van Herendael, Hugo ^b,c   De Raedt, Herbert ^b  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b CARDIOVASCULAR CENTER AALST   (Belgium)

^c NONE   (Belgium)

Author keywords

Atrioventricular block; Cardiac sarcoidosis; Corticosteroids; Heart failure

Indexed keywords

ADULT; ANAMNESIS; ARTICLE; ATRIOVENTRICULAR BLOCK; CASE REPORT; CLINICAL EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; ELECTROCARDIOGRAPHY; HUMAN; LABORATORY TEST; LYMPH NODE BIOPSY; MALE; SARCOIDOSIS; SYSTOLIC DYSFUNCTION;

ADULT; DIAGNOSIS, DIFFERENTIAL; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; HEART BLOCK; HUMANS; MALE; PACEMAKER, ARTIFICIAL; RADIOGRAPHY, THORACIC; SARCOIDOSIS;

EID: 34250330818     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.2143/AC.62.3.2020820     Document Type: Article

References (11)

1. Costabel U, Hunninghake GW. ATS/ERS/WASOG statement on sarcoidosis. Eur Respir J 1999; 14: 735-7.
2. Bargout R, Kelly RF. Sarcoid heart disease: clinical course and treatment. Int J Cardiol 2004; 97: 173-82.
3. Roberts WC, McAllister HA, Ferrans VJ. Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group I) and review of 78 previously described necropsy patients (group II). Am J Med 1977; 63: 86-108.
4. Yazaki Y, Isobe M, Hiroe M, Morimoto S, Hiramitsu S, Nakano T, Izumi T, Sekiguchi M. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol 2001; 88: 1006-10.
5. Le Guludec D, Menad F, Faraggi M, Weinmann P, Battesti JP, Valeyre D. Myocardial sarcoidosis. Clinical value of technetium-99 m sestamibi tomoscintigraphy. Chest 1994; 106: 1675-82.
6. Smedema JP, Snoep G, van Kroonenburgh MP, van Geuns RJ, Cheriex EC, Gorgels AP, Crijns HJ. The additional value of gadolinium-enhanced MRI to standard assessment for cardiac involvement in patients with pulmonary sarcoidosis. Chest 2005; 128: 1629-37.
7. Uemura A, Morimoto S, Hiramitsu S, Kato Y, Ito T, Hishida H. Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies. Am Heart J 1999; 138: 299-302.
8. Kiuchi S, Teraoka K, Koizumi K, Takazawa K, Yamashina A. Usefulness of late gadolinium enhancement combined with MRI and 67-Ga scintigraphy in the diagnosis of cardiac sarcoidosis and disease activity evaluation. Int J Cardiovasc Imaging 2007; 23: 237-41.
9. Takada K, Ina Y, Yamamoto M, Satoh T, Morishita M. Prognosis after pacemaker implantation in cardiac sarcoidosis in Japan. Clinical evaluation of corticosteroid therapy. Sarcoidosis 1994; 11: 113-7.
10. Aizer A, Stern EH, Gomes JA, Teirstein AS, Eckart RE, Mehta D. Usefulness of programmed ventricular stimulation in predicting future arrhythmic events in patients with cardiac sarcoidois. Am J Cardiol 2005; 96: 276-82.
11. Mezaki T, Chinushi M, Washizuka T, Furushima H, Chinushi Y, Ebe K, Okumura H, Aizawa Y. Discrepancy between inducibility of ventricular tachycardia and activity of cardiac sarcoidosis. Requirement of defibrillator implantation for the inactive stage of cardiac sarcoidosis. Intern Med 2001; 40: 731-5.